Annals of Surgical Oncology

, Volume 11, Issue 4, pp 445–452 | Cite as

Laparoscopic Sentinel Node Procedure for Cervical Cancer: Impact of Neoadjuvant Chemoradiotherapy

  • Emmanuel Barranger
  • Annie Cortez
  • Dany Grahek
  • Patrice Callard
  • Serge Uzan
  • Emile Darai
Original Articles


Background: SN detection based on combined blue dye and radiocolloid labeling can reliably show lymph node status in cervical cancer, but the influence of prior neoadjuvant chemoradiotherapy has not yet been reported. The aim of this study was to evaluate the effect of neoadjuvant chemoradiotherapy on the accuracy of a dual-labeling laparoscopic sentinel node (SN) procedure in patients with cervical cancer.

Methods: Between July 2001 and June 2003, 26 patients (mean age, 50.3 years) with cervical cancer underwent a laparoscopic SN procedure based on dual labeling with patent blue and radiocolloid. After the SN procedure, all the patients underwent complete laparoscopic pelvic lymphadenectomy and laparoscopic radical hysterectomy (n = 19), the Schauta-Amreich operation (n = 5), or trachelectomy (n = 2). The results of the SN procedure were compared between 11 patients who received neoadjuvant chemoradiotherapy and 15 patients who did not receive neoadjuvant treatment.

Results: The SN identification rates were 100% in the 11 patients who underwent neoadjuvant chemoradiotherapy and 93.3% in the 15 patients who did not receive adjuvant therapy. A total of 59 SNs were removed. Eight SNs (13.6%) from five patients (19.2%) were found to be metastatic at the final histological assessment. Three SN involvements were detected by hematoxylin and eosin staining of the SN. Immunohistochemical studies identified five metastatic SNs in three patients. There were no false-negative SN results.

Conclusions: This study suggests that SN detection with a combination of radiocolloid and patent blue is feasible and accurate in patients with cervical cancer undergoing neoadjuvant chemoradiotherapy or primary surgery. The combination of laparoscopy and the SN procedure permits minimally invasive management of cervical cancer.

Key Words:

Sentinel node biopsy Laparoscopy Cervical cancer Neoadjuvant chemoradiotherapy Trachelectomy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15–36PubMedCrossRefGoogle Scholar
  2. 2.
    Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339–48.PubMedGoogle Scholar
  4. 4.
    Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Peters WA III, Liu PY, Barrett RJ II, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606–13.PubMedGoogle Scholar
  7. 7.
    Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 1999; 85: 1547–54.PubMedCrossRefGoogle Scholar
  9. 9.
    Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P. Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998; 91: 360–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Magrina JF, Goodrich MA, Lidner TK, Weaver AL, Cornella JL, Podratz KC. Modified radical hysterectomy in the treatment of early squamous cervical cancer. Gynecol Oncol 1999; 72: 183–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Delgado G, Bundy BN, Fowler WC Jr, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989; 35: 314–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9.PubMedGoogle Scholar
  13. 13.
    Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 2002; 94: 2542–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994; 84: 163–7.PubMedGoogle Scholar
  15. 15.
    De Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000; 18: 2811–6.PubMedGoogle Scholar
  16. 16.
    Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001; 83: 276–81.PubMedCrossRefGoogle Scholar
  17. 17.
    O’Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000; 79: 238–43.PubMedCrossRefGoogle Scholar
  18. 18.
    Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000; 79: 411–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 2002; 20: 688–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Verheijen RH, Pijpers R, van Diest PJ, Burger CW, Buist MR, Kenemans P. Sentinel node detection in cervical cancer. Obstet Gynecol 2000; 96: 135–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Lantzsch T, Wolters M, Grimm J, et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer 2001; 85: 791–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Barranger E, Grahek D, Cortez A, Uzan S, Darai E. Laparoscopic sentinel node procedure in patients with cervical cancer. J Clin Oncol 2002; 20: 2602–3.PubMedGoogle Scholar
  23. 23.
    Lambaudie E, Collinet P, Narducci F, et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol Oncol 2003; 89: 84–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in patients with cervical carcinoma. Cancer 2003; 97: 3003–9.PubMedCrossRefGoogle Scholar
  25. 25.
    American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia: Lippincott, 1992: 155–7.Google Scholar
  26. 26.
    Querleu D. Laparoscopically assisted radical vaginal hysterectomy. Gynecol Oncol 1993; 51: 248–54.PubMedCrossRefGoogle Scholar
  27. 27.
    Navratil E. Radical vaginal hysterectomy (Schauta-Amreich operation). Clin Obstet Gynecol 1965; 8: 676–704.PubMedCrossRefGoogle Scholar
  28. 28.
    Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000; 88: 1877–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999; 92: 204–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Kamprath S, Possover M, Schneider A. Laparoscopic sentinel lymph node detection in patients with cervical cancer. Am J Obstet Gynecol 2000; 182: 1648.PubMedCrossRefGoogle Scholar
  31. 31.
    Malur S, Krause N, Kohler C, Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 2001; 80: 254–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001; 182: 312–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Julian TB, Patel N, Dusi D, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001; 182: 407–10.PubMedCrossRefGoogle Scholar
  34. 34.
    Stearns V, Ewing A, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9: 235–42.PubMedCrossRefGoogle Scholar
  35. 35.
    Haid A, Tausch C, Lang A, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001; 92: 1080–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Leveuf J, Godard H. Les lymphatiques de l’uterus. Rev Chir 1923; 61: 219–48.Google Scholar
  37. 37.
    Medl M, Peters-Engl C, Schutz P, Vesely M, Sevelda P. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res 2000; 20: 1133–4.PubMedGoogle Scholar
  38. 38.
    Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Nogushi M, Nakanishi M. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001; 80: 139–44.PubMedCrossRefGoogle Scholar
  39. 39.
    Rhim CC, Park JS, Bae SN, Namkoong SE. Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J Korean Med Sci 2002; 17: 507–11.PubMedGoogle Scholar
  40. 40.
    Van Dam PA, Hauspy J, Vanderheyden T, et al. Intraoperative sentinel node identification with technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer 2003; 13: 182–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Buist MR, Pijpers RJ, van Lingen A, et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol 2003; 90: 290–6.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2004

Authors and Affiliations

  • Emmanuel Barranger
    • 1
    • 4
  • Annie Cortez
    • 2
  • Dany Grahek
    • 3
  • Patrice Callard
    • 2
  • Serge Uzan
    • 1
  • Emile Darai
    • 1
  1. 1.Department of Gynecologic and Breast TumorsHôpital Tenon, Assistance Publique des Hôpitaux de ParisParisFrance
  2. 2.Department of PathologyHôpital Tenon, Assistance Publique des Hôpitaux de ParisParisFrance
  3. 3.Department of Nuclear MedicineHôpital Tenon, Assistance Publique des Hôpitaux de ParisParisFrance
  4. 4.Service de Gynécologie-ObstétriqueHôpital TenonParisFrance

Personalised recommendations